Marshall Wace, LLP Ocular Therapeutix, Inc Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 87,743 shares of OCUL stock, worth $720,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,743
Previous 429,592 79.58%
Holding current value
$720,370
Previous $2.94 Million 74.03%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.45 - $9.23 $2.2 Million - $3.16 Million
-341,849 Reduced 79.58%
87,743 $763,000
Q2 2024

Aug 14, 2024
BUY
$4.2 - $8.69 $1.8 Million - $3.73 Million
429,592 New
429,592 $2.94 Million
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $69,685 - $115,738
15,149 New
15,149 $78,000
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $2.17 Million - $3.46 Million
531,636 New
531,636 $2.21 Million
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $550,303 - $1.08 Million
-89,335 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.7 - $14.34 $739,343 - $1.09 Million
76,221 Added 581.22%
89,335 $893,000
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $176,121 - $251,264
13,114 New
13,114 $186,000
Q2 2020

Aug 13, 2020
SELL
$4.67 - $8.95 $151,929 - $291,170
-32,533 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$3.95 - $7.4 $128,505 - $240,744
32,533 New
32,533 $161,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $632M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email